SCHEMBL8034977

SCHEMBL8034977

CCCCC1CCc2ccc(O)cc2C1=O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 4/20 0.57
▸ CYP26A1 O43174 7/20 0.49
▸ NQO2 P16083 1/20 0.44
▸ MTNR1A P48039 1/20 0.44
▸ MTNR1B P49286 1/20 0.44
▸ PBRM1 Q86U86 1/20 0.44
▸ SGPL1 O95470 1/20 0.43
▸ S1PR1 P21453 1/20 0.43
▸ CYP24A1 Q07973 1/20 0.43
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ THRA P10827 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8030964 0.86 MEN1 (0.44) CYP19A1CYP26A1PBRM1THRATHRB
SCHEMBL8028175 0.81 CYP19A1 (0.61) CYP19A1CYP26A1NQO2MTNR1AMTNR1B
SCHEMBL8756180 0.80 CYP19A1 (0.58) CYP19A1HTR1A
SCHEMBL9638064 0.77 CYP19A1 (0.64) CYP19A1CYP26A1PBRM1CYP24A1ESR1
SCHEMBL28048794 0.77 ESR1 (0.59) CYP19A1NQO2MTNR1AMTNR1BESR1
SCHEMBL10534693 0.76 CYP19A1 (0.47) CYP19A1SGPL1S1PR1CYP24A1THRA
SCHEMBL8465475 0.76 CYP19A1 (0.78) CYP19A1CYP26A1CYP24A1ESR1ESR2
SCHEMBL6272342 0.75 CYP19A1 (0.57) CYP19A1THRATHRBHTR1A
SCHEMBL10536475 0.75 CYP19A1 (0.60) CYP19A1ESR1ESR2THRATHRB
SCHEMBL27919093 0.74 CYP19A1 (0.56) CYP19A1THRATHRBHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166031-A Substituted tetralins, chromans and related compounds in the treatment of asthma PFIZER INC, (US) 2000-12-26 — — US disclosed
EP-0288962-B1 Aryl-aralkyl ethers, processes for their preparation and pharmaceutical composition comprising them FUJISAWA PHARMACEUTICAL CO (JP) 1994-07-13 — — EP disclosed
CN-1024663-C Substituted tetralins for treating asthma PFIZER (US) 1994-05-25 — — CN disclosed
US-5061718-A BENZOTHIAZOLYLMETHOXY COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND THEIR USE AS ANTI-INFLAMMATORY OR ANTI-ALLERGENIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-10-29 — — US disclosed
US-5045548-A Lipoxygenase inhibitors FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-09-03 — — US disclosed
CN-1013442-B BICYCLIC COMPOUND PROCESSES FOR PREPN. THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FUJISAWA PHARMACEUTICAL CO (JP) 1991-08-07 — — CN disclosed
US-4965274-A Antiallergen, antiinflammatory agent; lipoxygenase FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-10-23 — — US disclosed
US-4923881-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS Fujisawa Phatmaceutical Co., Ltd. (JP) 1990-05-08 — — US disclosed
CN-1033277-A Substituted tetralinchromans and related compounds for the treatment of asthma PFIZER (US) 1989-06-07 — — CN disclosed
WO-1989003681-A1 SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA PFIZER INC. (US) 1989-05-05 — — WO disclosed
EP-0313296-A2 Substituted chromans and related compounds in the treatment of asthma PFIZER INC. (US) 1989-04-26 — — EP disclosed
CN-88102538-A New dicyclic compound, its preparation method and the pharmaceutical composition that contains this compounds — 1988-12-07 — — CN disclosed
EP-0288962-A2 Aryl-aralkyl ethers, processes for their preparation and pharmaceutical composition comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-11-02 — — EP disclosed
Send feedback